leisure time -WSS

leisure time

author：fashion 2025-09-05 07:01:01 - browse：797

Dallas Mavericks owner Mark Cuban reacts during a timeout in the game against the Golden State Warriors at American Airlines Center on March 22, 2023 in Dallas, Texas. – opinion coverage from STAT — Tim Heitman/Getty Images

Mark Cuban, the Dallas Mavericks owner and “Shark Tank” star, has been making headlines recently with his direct-to-consumer venture, Cost Plus Drugs. The company sells generic prescription drugs and boasts more than 2 million members. As a family medicine specialist who has firsthand experience with American households’ dissatisfaction with the state of the nation’s prescription drug marketplace, I believe the enthusiasm for Cost Plus Drugs reveals an appetite for alternatives to the status quo in the pharmaceutical industry.

Cuban claims the reason behind the success of Cost Plus Drugs is the company’s decision to bypass pharmaceutical benefit managers — the negotiating agents insurance companies hire to negotiate big pharma’s prices down. But that might not be the case. Instead, its success appears to lie in its choice to collaborate with affordable generic drug manufacturers rather than the major pharmaceutical companies.

Last year, the Department of Health and Human Services found that between July 2021 and July 2022, major pharma companies raised the list price on more than 1,200 drugs by an average of 31 percent. That’s 23 percent more than the country’s overall inflation rate during the same period. Meanwhile, generic drug companies saved the U.S. roughly $2.6 trillion from 2012 to 2021, according to the Association for Accessible Medicines, a trade group representing generic drug manufacturers.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Why the drug industry's warnings on the IRA's impact fall short

WSS

Assistant physicians can help address the primary care shortage

Zelenskyy on how Russian invasion may end, gratitude for US aid and Putin's weakness

What are cluster munitions? Biden defends decision to send controversial weapons to Ukraine

Free Covid tests will again be offered to all U.S. households

Titanic submersible victims' family mourns: 'Enormous tragedy and devastation'

What could happen if Russia blows up the Zaporizhzhia Nuclear Power Plant?

hotspot

leisure time

knowledge

Psychedelics group wrestles with new pharma identity

Ahead of NATO summit, Biden meets with King Charles for 1st time since coronation

United colonoscopy coverage change 'may cost lives,' doctors say

US intelligence assessment says Iran not currently developing nuclear weapons

State Dept. review finds Biden bears some blame for Afghanistan failures

Drinking water from half of US faucets contains PFAS: Study

Medicare proposal to cover medical devices draws a mixed reaction

Another man arrested in connection with shooting at Kansas nightclub

Virginia high school admissions case could be legal follow

UPS workers' union leader explains what's at stake as strike edges closer

focus

Fed up with FDA, ALS advocates consider a take

FDA approves Leqembi, a milestone in Alzheimer’s treatment

House panel to mark up pandemic

FDA panel to weigh safety of artificial wombs for preterm births

Bankrupt Pear's prescription app helped MassHealth save money, data suggests

Akili changes sales model for its ADHD video game treatment

entertainment

hotspot

focus

explore